1-4 of 4
Bruno Turlin
Close
Sort by
Journal Articles

Deferasirox Improves Liver Pathology In β-Thalassemia Patients with Transfusional Iron Overload

Yves Deugnier, MD, Bruno Turlin, MD, PhD, Victor Dong, MD, Vanessa Giannone, BSN, Yiyun Zhang, PhD, Louis Griffel, MD, Pierre Brissot, MD
Journal: Blood
Blood (2010) 116 (21): 4274.
https://doi.org/10.1182/blood.V116.21.4274.4274
Published: 2010
Journal Articles

Semi-Quantitative Assessment of Hemosiderin Distribution Accurately Reflects Reductions in Liver Iron Concentration Following Therapy with Deferasirox (Exjade ® , ICL670) or Deferoxamine in Patients with Transfusion-Dependent Anemia.

Yves Deugnier, Bruno Turlin, Martine Ropert, Mohamed Bejaoui, Miranda Athanassiou-Metaxa, Holger Cario, Elliott Vichinsky, Herbert Opitz, Catherine Ressayre-Djaffer, Bertrand Rabault, John Ford
Journal: Blood
Blood (2005) 106 (11): 2708.
https://doi.org/10.1182/blood.V106.11.2708.2708
Published: 2005
Journal Articles

Expression of the Iron Regulatory Peptide Hepcidin Is Reduced in Patients with Chronic Liver Disease.

Greg Anderson, PhD, David M. Frazer, PhD, Kim R. Bridle, PhD, Graeme A. Macdonald, MD, PhD, Jeffrey L. Smith, PhD, Bruno Turlin, MD, Nathan Subramaniam, PhD, Darrell H. Crawford, MD, PhD, Lawrie W. Powell, MD, PhD, Grant A. Ramm, PhD
Journal: Blood
Blood (2005) 106 (11): 3591.
https://doi.org/10.1182/blood.V106.11.3591.3591
Published: 2005
Journal Articles

Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function

Clinical Trials & Observations Brief Report
Lénaïck Détivaud, Elizabeta Nemeth, Karim Boudjema, Bruno Turlin, Marie-Bérengère Troadec, Patricia Leroyer, Martine Ropert, Sylvie Jacquelinet, Brice Courselaud, Tomas Ganz, Pierre Brissot, Olivier Loréal
Journal: Blood
Blood (2005) 106 (2): 746–748.
https://doi.org/10.1182/blood-2004-12-4855
Published: 2005